Sign in
4

Changes in Ownership

Boundless Bio, Inc. Filed Acc 0000950170-24-038702

Options or other derivatives

  • Chief Financial Officer acquired 32,468 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rubin Jami Chief Financial Officer 2024-03-27 Grant or award · Stock Option +32,468 32,468 D
Loading xslF345X05/ownership.xml…